UFP Technologies, Inc. (UFPT)
286.65
-5.79
(-1.98%)
USD |
NASDAQ |
Sep 03, 16:00
286.24
-0.41
(-0.14%)
After-Hours: 17:18
UFP Technologies Cash from Investing (Quarterly) : -1.102M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.102M |
| March 31, 2026 | -1.688M |
| December 31, 2025 | -3.856M |
| September 30, 2025 | -15.27M |
| June 30, 2025 | -5.65M |
| March 31, 2025 | -2.817M |
| December 31, 2024 | -3.884M |
| September 30, 2024 | -197.17M |
| June 30, 2024 | -7.381M |
| March 31, 2024 | -1.732M |
| December 31, 2023 | -2.756M |
| September 30, 2023 | -2.785M |
| June 30, 2023 | -2.77M |
| March 31, 2023 | -2.177M |
| December 31, 2022 | -2.964M |
| September 30, 2022 | 33.40M |
| June 30, 2022 | -6.168M |
| March 31, 2022 | -22.98M |
| December 31, 2021 | -97.23M |
| September 30, 2021 | -0.965M |
| June 30, 2021 | -1.812M |
| March 31, 2021 | -1.449M |
| December 31, 2020 | -1.309M |
| September 30, 2020 | -0.828M |
| June 30, 2020 | -1.117M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.007M |
| December 31, 2019 | -1.393M |
| September 30, 2019 | -1.562M |
| June 30, 2019 | -1.431M |
| March 31, 2019 | -1.388M |
| December 31, 2018 | -0.907M |
| September 30, 2018 | -1.521M |
| June 30, 2018 | -1.469M |
| March 31, 2018 | -78.43M |
| December 31, 2017 | -3.501M |
| September 30, 2017 | -2.409M |
| June 30, 2017 | -3.007M |
| March 31, 2017 | -1.458M |
| December 31, 2016 | -1.206M |
| September 30, 2016 | -1.717M |
| June 30, 2016 | -2.758M |
| March 31, 2016 | -1.598M |
| December 31, 2015 | -3.296M |
| September 30, 2015 | -2.542M |
| June 30, 2015 | -1.939M |
| March 31, 2015 | -8.491M |
| December 31, 2014 | -2.468M |
| September 30, 2014 | -3.601M |
| June 30, 2014 | -5.878M |
| March 31, 2014 | -1.377M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -673.00M |
| AngioDynamics, Inc. | -1.27M |
| Alphatec Holdings, Inc. | -22.72M |
| AtriCure, Inc. | -3.766M |
| Baxter International, Inc. | -117.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 15.61M |
| Cash from Financing (Quarterly) | -25.36M |
| Free Cash Flow | 61.42M |
| Free Cash Flow Per Share (Quarterly) | 1.856 |
| Free Cash Flow to Equity (Quarterly) | 34.18M |
| Free Cash Flow to Firm (Quarterly) | 15.80M |
| Free Cash Flow Yield | 2.75% |